Earli is a series a startup based in United States. 1 investor tracked.
Earli is a company founded in 2018 headquartered in Germany. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Earli develops a platform that uses AI-designed genetic switches to force cancer cells to produce detectable synthetic biomarkers, enabling early cancer detection and targeted therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.